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eter stenosis. This clinical benefit was achieved without adversely affecting
other important aspects of the intewention. Procedural variables (expressed
per lesion; ICUS group vs standard group) which were not different between
the two groups included: rate of stent implantation (49% vs 49%, p = ns),
procedure time (63 *37 vs 6 + 36 rein, p = ns), contrast use (207+ 104 vs
197 + 97, p = ns), and maximal inflation pressure (12.4 k 3.6 vs 12,2 + 6.1
atm, p = ns). Device consumption (expresaed per lesion) favored the ICUS-
guided group: # balloons (1.22 * 0.94 vs 1.39 * 1.03, p = 0.10), #stents
(0.84 + 0.98 vs 0.62 & 0.94, p = ns), guide catheters (1.01 & 0.81 vs 1.10 +
0.77, p = ne) and guide wires (1.0* 0.76 vs 1.08 + 0.77, p = ns).
Weconclude that the benefitSof ICUS-guided interventionmaybe achieved
at no increase in procedure time or adverse effect on device utilization. The
long term coet effectiveness of this strategy will be assessed after 6 month
follow up now in progress.
D99448 Longitudinal Radiatribution of Plaqua ia anImportant Mechanism for Lumen Expansion in
Stenting
Y. Honda, C.A. Yock, J.B. Hermiller, P.J. Fitzgerald, P.G.Yock, for the
MULTI-LINK’MInvestigator. Stanford Univereiv, %enford, CA, USA, .9.
Vincent Hospital, Indianapolis, IN, USA
The mechanism for increasing lumen dimensions in coronay stents is poorly
understood. The ACS MULTI-LINK’” Stent has the unique property that the
media-adventitia interface can be clearly visualized through the stent with
intracoronaty ultrasound (lVUS). Analysis of the IVUScross-sectional images
of 47 patients treated with this stent showed a 10.2% (p < 0.01) decrease
in plaque area in the stented lesion between deployment (8 atm) and final
postdilatation (216 atm). There was a corresponding trend for increased
plaque area in the reference segments (7.6%, p = 0.2). To further determine
the mechanism of Iuminal improvement, we performed serial volumetric
IVUS analysis in eight coronay lesions. Motorized transducer pullback at 0.5
mtisec enabled measurements of vessel, plaque and stent or lumen areas
at 1 mm axial intervals. Calculated vessel, lumen, and plaque volumes (PV)
using Simpson’s rule at the stent and the reference sites were compared
before and after balloon inflations. Resu/fs: [1] Plaque volume in the stented
region significantly decreased after additional balloon inflation (p c 0.05)
while no significant increase in vessel volume was observed. [2] Plaque
volume at the reference sites significantly increased after inflation (p < 0.01);
however, the total plaque volume of the stent plus reference sites remained
unchanged.
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Cone/usiorr: Longitudinal redistribution of plaque out of stents, rather
than vessel expansion or plaque compression, appears to be a primary
mechanism of lumen gain after balloon inflation inside the stent.
D99449 Ultrasound (lCUS)-Guided Intervention Reaults inFewer Acute Major Adverae Cardiac Events
(MACE): Findings From the Strategy of
ICUS-Guided PTCA and Stenting (SIPS) Trial
A.W. Frey, C. Muller, H. Roskamm, J.McB. Hodgson. fferz Zentr’um,Bad
Krozingen, Germany
The SIPS trial randomized all consecutive patients except those with chronic
total occlusions to an interventional strategy of either primary treatment using
a combined ICUS/balloon catheter (Oracle Focus, Endosonics) (ICUS group)
or standard angiographically guided therapy (STD group) (n = 269 patients,
355 lesions). Procedural success was obtained in 96.7% of the ICUS and
Patisnta Infarct TLR MACE
Icus STD Icus STD Icus STD
All 1 (0.8) 3 (2.0) 2 (1,6) 8 (5.4) 3 (2.5) 11 (7,4)*
PTCA o 2 (1.4) 1 (0.8) 7 (4.7)* 1 (0.8) 9 (6.1)”
Stent 1 (0.8) 1 (0.7) 1 (0.8) 1 (0.7) 2 (1.6) 2 (1.4)
lChi-equare p < 0.05
92.6%of the STDgroup. Acute phase in-hospital myocardial infarction, target
lesion revascularization (TLR), and total MACE were compared. Stents were
placed in 49% of each group (p = ns). There were no deaths. Data in the
table displayed as # patients (Y.).
We conclude that acute MACE are reduced by a strategy of ICUS-guided
intervention. In this group of consecutive patients, such a strategy reduced
serious events by 66%. The beneficial effeti was confined to those patients
having only PTCA. The late clinical impact of this strategy will be assessed
after 6 month follow up angiography.
1994-501 Role of AdjunctiveBalloon Angioplasty Following
Coronary Atherectomy: A Serial Intravascular
Ultrasound Analysis from tha ABACAS Trial
H. Hosokawa, O. Kate, H. Tamai, T. Yamaguchi, T. Aizawa, T. Suzuki, for
the ABACAS Investigators. National ToyohashiHigashi Hospital, Toyohashi,
Japan
Adjunctive BalloonAngioplasty Following Coronary Atherectomy Study(ABA-
CAS) isa randomized multicenter registry to assess the impact of aggressive
debuiking using intravascular ultrasound (IVUS) guidance and adjunetive
PTCA on acute and long-term outcomes. A total of 214 patients (pts) were
prospectively randomized to DCA alone or to DCA with adjunct PTCA. In
66 pts out of 214 pts, prospective serial IVUS was performed at pre and
post-procedure, and at 6 months or earner if symptoms occurred.
Resu/ts: IVUS parameters at lesion site areas follows:
DCA alone (n = 43) DCA + PTCA (n= 41) P
Vessel CSA pre 14,7 * 18,6 15.9 + 26.2 ns
post 15.7 + 16.7 17.9 + 25.4 0.02
6M FU 15.6 + 24,0 16.5 + 30.3 ns
LumenCSA pre 3.3 & 2.7 3.5 * 3.0 na
peat 8,6 k 6.4 10.1 * 9.7 0.01
6M FU 6.1 + 10.1 6.1 + lo.a ns
P + M CSA pre 11.5 + 17.2 12.5 + 20,5 ns
poet 7.1 + 9.6 7.8 + 11,6 ns
6M FU 9.5 * 9.5 10.4 + 21.6 ns
CSA = cross-sectionalaree (mm2), P + M = plaque+ media
Before randomization (post-DCA), sufficient dubulking was achieved up
to a % plaque CSA of 46Y0in both group. Angiographic restenosis (% DS >
50%) occurred in 167. with no significant difference between DCA alone and
DCA + PTCA (16% VS 17%, p = NS).
Cone/usions.’After aggressive DCA, adjunctive PTCAcanachieve a larger
lumen, mainly by causing an enlargement of vessel area. However, serial
IVUS study showed no beneficial effect of adjunctive PTCAfollowing DCA at
follow-up.
1994-251OutcOmeAfterRecana,i~tionof Chronic Coronary
Occlusions in Relation to Quantitative
Intravascular Ultrasound Findings
GS. Werner, J. Diedrich, A.B. Buchwald, H. Kreuzer. Dept. of Cardiology
University of Goeffingen, Germany
Chronic coronary occlusions (TCO) carry a high recurrence rate after coro-
nary angioplasty (PTCA). To determine potanfial factors of Iata outcome,
intravascular ultrasound (NJ)measurements after recanalization were mm-
pared in vessels with and without raocclusion or raetenosis. 62 consecutive
pts with a TCO (duration more than 4 weeks) underwent IU during a suc-
cessful recenalization. On-line IU measurement of the proximal and distal
reference segment were done to adjust the balloon size. The Iuminal area
(LA), the area stenosis (LS), and the lumen deficit (LD) relative to the bal-
loon size, were calculated. In 30 cases of dissections (n = 13), or a LS >
50% coronary stents were implanted. 65Y0of all pts completed angiographic
follow-up after6 months. The balloon size forthefinal dilatation was adjusted
according to the IU measurement of the reference segments. In stented ves-
sels LS was –8 * 6% vs. 26 + 12% in nonstented vessels (p < 0.001),
and LD 23 + 97. vs. 37 + 14% (p < 0.01). 6 reocclusions and 9 reatenosis
were obsewed in nonstented vessels, one subacute stent thrombosis, no late
reocclusion and 4 restenosis were observed in stented vessels. Considering
only those pts, who had completed control angiography, the recurrence rate
without stent was 62’%.,and 22% with stents. When comparing outcome and
quantitative IU measurements durfng recanalization in nonstented vessels,
LA was lower in vessels with recurrence (4.0 + 1.3 vs. 5.3 & 1.6 mm2, p <
0.05), and LD was higher (39 + 137. vs 29 & 12%; p c 0.05). Likewise in
stented lesions, LA was significantly smaller in restenotic lesions (5.7 l 1.4
mmZVs7,9 & 1.9 mmz;p<0.05), whereas LD was similar.
The high recurrence rate in TCO appeared to be related to the absolute
Iuminalarea achieved by PTCA.Stent implantation with a Iargeracute Iuminal
